戻る Agenda
S14 : Can RWD Address Patient Enrollment Challenges? – Toward a Future Where Effective RWD Use Is Standard in Drug Development
Session Chair(s)
Jun Sakurai
Assistant Professor, Center for Innovative Clinical Medicne, Okayama University Hospital, Japan
Speaker(s)
Tomoyuki Takase
, Eli Lilly Japan K.K., Japan
Kanako Katsuyama
Assistant Director, Pharmaceutical Safety Division, Pharmaceutica, Ministry of Health, Labor and Welfare, Japan
Takenori Ogawa
General Manager, Clinical Trial Division, EBM Division, Medical Data Vision Co., Ltd., Japan
Daisuke Nosaka, MD, PHD
Medical Science Department, Medial Affairs Division, Chugai Pharmaceutical Co., Ltd., Japan